Adicet Bio to Participate in Guggenheim 2022 Oncology Conference

Rhea-AI Summary

Adicet Bio, Inc. (NASDAQ: ACET) announced that CEO Chen Schor will participate in a virtual fireside chat at the Guggenheim 2022 Oncology Conference on February 9, 2022, at 11:30 am ET. Investors can access the live audio webcast through the company's website, with an archived replay available for 30 days post-event. Adicet Bio is focused on developing allogeneic gamma delta CAR T cell therapies targeting cancer and other diseases, emphasizing durable anti-tumor immune responses.

MENLO PARK, Calif. & BOSTON--(BUSINESS WIRE)-- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta CAR T cell therapies for cancer and other diseases, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim 2022 Oncology Conference taking place virtually on February 9-11, 2022.

Details of the event are as follows:

Date: Wednesday, February 9, 2022
Time: 11:30 am ET

A live audio webcast of the fireside chat can be accessed on the Investors section of Adicet Bio’s website at https://investor.adicetbio.com. An archived replay will be available for 30 days following the presentation.

About Adicet Bio, Inc.

Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220201006166/en/

Adicet Bio., Inc.

Investor Contacts

Anne Bowdidge

abowdidge@adicetbio.com

Janhavi Mohite

Stern Investor Relations, Inc.

212-362-1200

janhavi.mohite@sternir.com

Source: Adicet Bio, Inc.

FAQ

What is Adicet Bio's stock symbol?

The stock symbol for Adicet Bio is ACET.

When is the Guggenheim 2022 Oncology Conference?

The Guggenheim 2022 Oncology Conference takes place from February 9-11, 2022.

Who is participating in the Guggenheim 2022 Oncology Conference?

CEO Chen Schor will participate in the fireside chat at the conference.

How can I access the Adicet Bio fireside chat?

You can access the live audio webcast of the fireside chat on Adicet Bio's investor website.

What type of therapies does Adicet Bio develop?

Adicet Bio develops allogeneic gamma delta CAR T cell therapies for cancer and other diseases.